AELIX Therapeutics is a clinical stage biotechnology company based in Barcelona, Spain, focused on the development of a therapeutic HIV vaccine to be used in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, a Catalan public-private consortium conducting cutting-edge research in the field of AIDS. The HIVACAT programme, which aims to develop strategies to prevent and cure HIV and AIDS, is led by IrsiCai...
AELIX Therapeutics is a clinical stage biotechnology company based in Barcelona, Spain, focused on the development of a therapeutic HIV vaccine to be used in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, a Catalan public-private consortium conducting cutting-edge research in the field of AIDS. The HIVACAT programme, which aims to develop strategies to prevent and cure HIV and AIDS, is led by IrsiCaixa Aids Research Institute and the Infectious Diseases and AIDS Unit of the Hospital Clínic of Barcelona. The HIVACAT consortium licensed the HTI technology to AELIX Therapeutics
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.